NEUREN PHARMACEUTICALS LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of NEU for the last semiannual is 169.00 M AUD, and it's 168.57% higher compared to the previous semiannual. The net income of H2 23 is 109.28 M AUD.